about
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older PeopleInappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter studyAssessment of nursing home residents in Europe: the Services and Health for Elderly in Long TERm care (SHELTER) studyQuality of care in European home care programs using the second generation interRAI Home Care Quality Indicators (HCQIs)Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancerAging, disability and frailty.Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals.Nutrition in the age-related disablement process.Treating heart failure in older and oldest old patients.Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults.Narcolepsy with cataplexy in patients aged over 60 years: a case-control study.Unintended weight loss in the elderly living at home: the aged in Home Care Project (AdHOC).The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods.Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment.Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease.Delivery of Care to Nursing Home Residents With Diabetes: Results From the SHELTER Study.Dual Sensory Impairment and Cognitive Decline: The Results From the Shelter Study.Joint Associations of Dual Sensory Impairment and No-Activity Involvement With 1-Year Mortality in Nursing Homes: Results From the SHELTER Study.The characteristics of diabetic residents in European nursing homes: results from the SHELTER study.Urinary incontinence in nursing home residents: a cross-national comparison.Influenza and pneumococcal vaccination in older adults living in nursing home: a survival analysis on the shelter study.Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study.Pain characteristics and pain control in European nursing homes: cross-sectional and longitudinal results from the Services and Health for Elderly in Long TERm care (SHELTER) study.Treatment of pain in European nursing homes: results from the Services and Health for Elderly in Long TERm Care (SHELTER) study.Prevalence and correlates of hearing and visual impairments in European nursing homes: results from the SHELTER study.Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012.Urinary incontinence and use of pads--clinical features and need for help in home care at 11 sites in Europe.Interactions between drugs and geriatric syndromes in nursing home and home care: results from Shelter and IBenC projects.Insomnia in long-term care facilities: a comparison of seven European countries and Israel: the Services and Health for Elderly in Long TERm care study.Health determinants and survival in nursing home residents in Europe: Results from the SHELTER study.Hearing the Voice of the Resident in Long-Term Care Facilities-An Internationally Based Approach to Assessing Quality of Life.Higher body mass index in narcolepsy with cataplexy: lifelong experience.Polypharmacy in nursing home in Europe: results from the SHELTER study.Impact of dual sensory impairment on onset of behavioral symptoms in European nursing homes: results from the Services and Health for Elderly in Long-Term Care study.Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study.Care for elders with chronic disease and disability.Relationship between the Gérontopôle Frailty Screening Tool and the frailty phenotype in primary careHealthy brain ageing and cognition: Nutritional factorsThe MPI_AGE European Project: Using Multidimensional Prognostic Indices (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons. Background, aim and design
P50
Q24633789-02B106EF-0200-43B4-AE00-4D9F60EC9F6EQ28484216-779D7C00-983F-4208-8DA6-39E912DFC6ECQ34122240-4FF9566B-BD06-4E46-AC28-5874C4A0FCEEQ35842658-874F67B3-A165-4503-82F1-2FC9CC25486BQ36220834-4C8523CE-D16E-44B8-A49B-4D619C5C480DQ36925135-6329BA93-ACD0-4F14-8B7F-386FECB2BBC4Q37125602-8A418629-08A8-4CAB-9228-809377762254Q37876357-81CA1D04-312C-4CED-A171-68052487919FQ37942039-2BF6A15A-DCC9-4AB9-AA01-39508111ABEFQ38336548-B589D470-1248-49A0-9ACF-7D1527D5054EQ38894208-A698A42B-6E4A-4A32-B23E-80A3239EADB4Q39353884-45064738-D080-4580-B575-B91557E39B25Q39827471-BF88426F-17E3-49DD-B45C-42E2AD6314A6Q40356401-99C65FA6-92C0-4B22-B2FE-C1BF3D8D1B34Q40361649-DDBCFE24-2329-4ED8-95FF-6FEF96C176FFQ40565108-13D0BF58-D676-4912-B6A9-ED91ADBF0B0CQ40683127-BEEF8159-8B8D-4D01-A28C-337C2DFB5E67Q41079057-1585BD1F-9FF7-438D-8412-D8E07D71E300Q41114829-0551A922-32E0-469D-A5D8-9BDCFC07224FQ41658118-30A61E92-6DE6-4258-A33B-E257D1F58252Q42672445-7D912758-7633-4CAD-9CE4-093E8247DA57Q42699095-18427428-AA7F-42F6-8409-EDF6F517B5B8Q43522765-76DBEB2E-DA9D-4885-98DF-B518935BC44DQ44441365-B9F3A138-BA02-46CD-9369-6BDF61A9B0F8Q45002028-10C68497-2FCF-4A02-B046-D3AC5C182C07Q45417884-3A2A4E3A-4440-4F3F-A1EF-4F500E927B21Q45760984-90F1B276-6855-4E79-BE96-170849AE25D5Q47351812-6FAD2F56-AA96-4D73-9031-E926BED22666Q47558485-706B081D-2EDD-46EF-941B-7370A924C012Q47592192-6E84CDC2-48F5-4682-AE6A-16113C6D5E1BQ47601195-E74EF09A-C5BD-4E29-937D-9369C5EF0646Q47655422-BA29AA2F-A7F5-4817-855B-BC378C490202Q47779565-EEBF7897-10FF-45A7-BDA5-DF93B8A9352CQ48766193-D3DC590E-D82B-43C7-A546-75996E892295Q50353449-5A05A09B-AAAA-41F2-9222-2E43C7A95B52Q53087437-B984F46B-FF87-42CB-A05C-3586BDCA1263Q53658110-40B23229-6B3F-44D2-AE25-F475517A3EB6Q57415554-4F22B754-F756-413C-BE3E-D2BB60C4A811Q58006495-F52232BB-492F-467A-8B44-683FF3D25C1BQ58946239-435492EE-1B67-4A9F-97A0-66EA0DF02391
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Eva Topinkova
@ast
Eva Topinkova
@en
Eva Topinkova
@es
Eva Topinkova
@nl
type
label
Eva Topinkova
@ast
Eva Topinkova
@en
Eva Topinkova
@es
Eva Topinkova
@nl
prefLabel
Eva Topinkova
@ast
Eva Topinkova
@en
Eva Topinkova
@es
Eva Topinkova
@nl
P1153
57197366993
7003434686
P21
P31
P496
0000-0002-6786-4116